Background--Cell-based therapies involving mononuclear cells (MNCs) have been developed for vascular regeneration to treat ischemic diseases; however, quality control of therapeutic MNCs has not been evaluated. We investigated the therapeutic potential of peripheral blood (PB) MNCs, operated by recently developed quality and quantity (QQ) culture of endothelial progenitor cells (EPCs).
B
ased on the isolation of bone marrow (BM)-derived endothelial progenitor cells (EPCs), [1] [2] [3] autologous total mononuclear cells (MNCs) freshly isolated from BM or peripheral blood (PB) have been applied to clinical vascular regenerative therapy in patients with severe ischemic heart or limb diseases.
These initial clinical experiences indicate that cell-based therapy for vascular regenerations is safe, feasible, and effective. [4] [5] [6] [7] However, the translational and clinical trials have also demonstrated insufficient or contradictory effectiveness on recovery from ischemic diseases. [8] [9] [10] [11] Peripheral blood and bone marrow MNCs (PBMNCs and BMMNCs) constitute hematopoietic lineage cells; most are lymphoid cells or myeloid monocytes, and very few are stem/ progenitor cell types, such as hematopoietic stem/progenitor cells, EPCs, or other mesenchymal stem cells. The scarcity of EPCs in MNC populations is a main reason for failure of constant and potent contributions in clinical cases.
Enriched EPCs, such as CD34 + or CD133 + cells, constitute <0.01% of PBMNCs and 0.1% of BMMNCs, and the frequency of colony-forming EPCs is 0.005% in PBMNCs. 12 Taking into account the majority in MNCs, we need to issue the critical functions of monocyte/macrophages. Monocytes are precursors of macrophages; monocytes play key roles in both proinflammatory and regenerative processes by phenotype alterations after tissue infiltrations. 13 Macrophages are a heterogeneous cell population that adapts and responds to a large variety of microenvironmental signals. For example, the cytokines and growth factors in some microenvironments induce macrophages to adopt regenerative phenotypes, whereas the inflammatory deterioration and fibrosis in uncontrolled inflammatory environment in tissues induce proinflammatory macrophage transitions and suppress regenerative processes. Also, the inflammatory environment is interacted by major lymphoid phenotypes simultaneously stimulated by proinflammatory signals and controlled macrophage phenotype transition for proinflammatory drive. 13, 14 To suppress unproductive inflammatory process and enhance vasculogenic regeneration, purified EPCs have been transplanted into patients with severe ischemic heart or limb diseases, and these initial clinical experiences indicate that this cell-based therapy is safe and effective. [15] [16] [17] [18] [19] Nevertheless, the problems caused by EPC scarcity must be overcome for EPCmediated therapy to become reproducible and effective. To this end, the following 3 step-wise strategies have been used: (1) leukapheresis; (2) daily administration of granulocyte colony-stimulating factor (G-CSF); and (3) isolation of machinery CD34 + or CD133 + cells. Such an isolation process of autologous EPC sources burdens the patients to be treated with "EPC therapy," in terms of medical invasiveness and costs. More important, the number and functionality of EPCs decline as patients age 20 and in patients with cardiovascular (CV) risk factors. 21, 22 Here, we describe a method for MNC culture that enhances the vasculogenic potential of EPCs and facilitates the preparation of monocytes for regenerative phenotype activation.
Our method for quality and quantity-control culture (QQ culture) of MNCs (QQMNCs) is based on an established culture method that increases the quality and quantity of EPCs derived from enriched EPC populations, such as CD34 + and CD133 + cells. Notably, the therapeutic potential of QQ culture is demonstrably greater than that of na€ ıve EPCs for CV regeneration after infarcted myocardia in rats. 23 Interestingly,
we found that the vasculogenic signaling condition of MNCs in QQ culture potentiates the vascular and tissue regeneration ability of na€ ıve PBMNCs. The regenerative function of QQMNCs turned out to be operated through activation of anti-inflammatory and angiogenic monocytes/helper T lymphocytes as well as vasculogenic EPC expansion.
Moreover, the present experimental study demonstrated that therapeutic efficacy of QQMNC transplantation (QQMNCTx) is equal to and greater than that of G-CSF mobilized CD34
+ cell Tx (GmCD34Tx).
Therefore, in cell-based therapy for ischemic diseases, QQMNC provides a practical option of cell sources, including PBMNC and GmCD34.
Methods

Collection of PBMNCs Cells or CD34 + Cells From Healthy Volunteers
Experiments using human samples were performed with institutional approval and guidelines from the Clinical Investigation Committee at Tokai University School of Medicine (institutional review board [IRB] No.: 10R-020; irb.med.u-tokai.ac.jp/d/2/monthly/2010.html and IRB No.: 13R228; irb.med.u-tokai.ac.jp/d/2/monthly/201312.html). The whole healthy human volunteers between the ages of 20 and 55 years gave informed consent.
PB (20 to 100 mL per subject) was drawn by heparinized venous puncture at the forearm. PBMNCs were isolated by density gradient centrifugation using Lymphocyte Separation Solution (d=1.077; Nakalai Tesque, Kyoto, Japan), as previously reported. 24 CD34 + cells were purified by an autoMACS separator (Miltenyi Biotec, Lund, Sweden), using magnetic beads-coated mouse anti human CD34 antibody (Ab) and a CD34 Cell isolation kit (Miltenyi Biotec), according to the manufacturer's instructions.
Then, isolated PBMNCs were cultured for 7 days at the cell density of 2910 6 cells/2 mL QQ culture medium per well of 6-well Primaria tissue culture plate (BD Falcon; BD Biosiences, San Jose, CA). Cell density in QQ culture was corresponded to the approximate density of 1910 6 MNCs in 1 mL of PB.
Culture well plates and the contents of QQ culture medium are listed in Tables 1 and 2 .
Early EPC culture of PBMNCs
As previously reported, 24, 25 early EPCs (eEPCs) were acquired after 7 days of culture of isolated PBMNCs using the EGM-2-MV SingleQuots kit (Lonza Walkersville, Inc., Walkersville, MD). In brief, EGM-2-MV complete medium was adjusted by adding 5% FBS (SAFC Biosciences Inc., Lenexa, KS) and supplemented growth factors, except hydrocortisone, to EBM-2 basal medium. PBMNCs were adjusted to the similar cell density (1910 6 cells/mL) with 5% FBS/EGM-2-MV complete medium to that in QQ culture of PBMNCs. Cells were then plated on a human fibronectin-coated 6-well Primaria tissue culture plate (2910 6 cells/2 mL per well) and cultured. The medium was changed 4 days after seeding, then cultured for 3 more days. Seven days later, nonattaching cells were removed; adherent cells were harvested with 2 mmol/L of EDTA/PBS after washing with PBS. Harvested eEPCs were suspended in Iscove's Modified Dulbecco's Medium (IMDM) (Sigma Aldrich), adjusted the cell density (1910 4 cells/40 lL or 2910 5 cells/ 40 lL), cells were then transplanted into skeletal muscle of murine ischemic hindlimb, as described below.
EPC Colony-Forming Assay
To investigate the vasculogenic potential of PBMNCs or QQMNCs, we used semisolid culture medium and 35-mm Primaria dishes (BD Falcon; BD Biosciences) to grow and then counted the adhesive EPC colonies by EPC colony-forming assay (EPC-CFA) (MethoCult SF BIT ; STEMCELL Technologies Inc., Vancouver, BC, Canada) with proangiogenic growth factors/ cytokines, as previously reported (Table 3) . 12 Aliquots of those cells were seeded at 2910 5 cells/dish (3 dishes per volunteer)
for EPC-CFA. Sixteen to 18 days after initiation of the culture, the number of adherent colonies per dish was measured using a gridded scoring dish (STEMCELL Technologies) under phasecontrast light microscopy (Eclipse TE300; Nikon, Tokyo, Japan). Primitive EPC colony-forming units (pEPC-CFUs) and definitive EPC-CFUs (dEPC-CFUs) were separately counted.
Flow Cytometry
Performance of flow cytometry for lineage cell populations
Freshly isolated PBMNCs and the QQMNCs were subjected to flow cytometry (FCM) to detect surface antigen positivities 
FCM analysis
The scatter diagram of each PBMNC, or the QQ cultured cell (QQMNC) population in an individual, was gated into 3 cellsized populations of lymphocytes, monocytes, and the larger cells. The percent (%) positivity of a hematopoietic cell population per each gate in PBMNCs or QQMNCs was evaluated and then calculated to that in the whole cells of the 3 gates. The ratio of the % positivity in the whole cells of QQMNCs to that in PBMNCs was further calculated for each cell population. Similarly, the % positivity of each helper T subset (Th1, Th2, or regulatory T cell) was calculated in CD4 
Making ischemic hindlimb model and cell Tx
Eight-to 10-week-old male BALB/c nu/nu mice (CAnN.CgFoxn1 nu /CrlCrlj; Charles River Laboratories Japan, Inc., Tokyo, Japan) were used, as reported elsewhere. 26 The proximal portion of the left femoral artery, including the superficial and the deep branch, was suture-ligated, and the proximal and distal portions of the saphenous artery were occluded with a bipolar forcep electric coagulator (MERA N3-14; SENKO MEDICAL INSTRUMENT mfg. Co., Ltd., Tokyo, Japan). The overlying skin was closed with a 6-0 silk suture. The next day, cells were suspended in IMDM medium and intramuscularly injected into ischemic hindlimbs. The cell injection sites and the doses for assays were as follows: each one site of anterior tibial muscle (ATM) and gastrocunemius muscle (GCM) for blood flow analysis and histology, that is, hematoxylin and eosin (H&E) staining, Azan staining, and inducible nitric oxide synthase (iNOS) 
Ang indicates angiopoietin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IGF, insulin-like growth factor; IL, interleukin; MMP, matrix metalloproteinase; PBMNCs, peripheral blood mononuclear cells; QQMNCs, quality and quantity control culture of mononuclear cells; qRT-PCR, quantitative real-time polymerase chain reaction; TGF, transforming growth factor; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.
excised and embedded into paraffin for the tissue sample preparation. Alternatively, the muscles, after QQMNCTx, GmCD34Tx, and eEPCTx, were coated with optimal cutting temperature (O.C.T.) compound (Tissue-Tek; Sakura Finetek Japan Co., Ltd., Tokyo, Japan), immediately frozen in liquid nitrogen, and refrigerated until use at À80°C. Cross-sectional tissue samples with the thickness at 6 to 8 lm for paraffin section or at 10 lm for frozen sections, were sliced from tissue blocks of muscles and then subjected to assessments as described below.
Microvascularture and pericyte recruitment
For alpha-smooth muscle actin (a-SMA) staining, paraffin tissue sections, after deparaffinization or the frozen ones, were washed with PBS, blocked with 10% goat serum for 30 minutes at room temperature (RT), then, incubated with Cy3-conjugated anti-a-SMA Ab (Sigma-Aldrich) and prediluted (1:200 ratio) with 1% BSA/PBS for 2 hours at RT. After washing with PBS, sections were mounted with 1.
then observed using a fluorescent microscope (Biorevo; Keyence Corporation, Osaka, Japan). The same protocol, without using the Ab, was performed as the negative control. Also, the negative control for Isolectin B4-FITC staining was in advance, prepared from the mice without in vivo injecting Isolectin B4-FITC into the tail vein. Using software (VH analyzer; Keyence), microvascular densities were evaluated by counting the microvessels stained with Isolectin B4-FITC. Simultaneously, pericyte recruitment to the vasculartures was evaluated by counting the a-SMA-positive microvessels.
Myogenesis and interstitial fibrosis
Centrally nucleated muscle fibers stained with H&E were photographed with an automatic research photomicroscope (AX80; Olympus) and were then counted as regenerating muscle fibers implying fusion of myoblasts 27 by VH analyzer (Keyence). Limb interstitial fibrosis detected by Azan staining was morphometrically assessed by the same photomicroscope and software.
28,29
Tissue inflammation
Paraffin tissue sections were deparaffinized, autoclaved in citrate buffer at 121°C for 10 minutes to retrieve the target antigen, incubated with the primary Ab of rabbit polyclonal antiiNOS Ab (Abcam, Cambridge, MA) prediluted with 1% BSA/PBS (1:100 ratio) at 4°C overnight (Table 8) . Thereafter, samples were treated with 0.3% H 2 O 2 /methanol and Histofine Simple Stain MAX PO (Nichirei Biosciences Inc., Tokyo, Japan) and then dyed with 3,3 0 -diaminobenzidine, tetrahydrochloride (DAB; Dojindo, Kumamoto, Japan). Furthermore, the samples were stained with hematoxylin, dehydrated, and then mounted with malinol. Frozen tissue sections were also stained with the antiiNOS Ab in the same way, after similar autoclave and subsequent treatment with 0.5% Triton X-100/PBS. Control samples were prepared under the same procedure, using rabbit immunoglobulin fraction (DAKO, Tokyo, Japan).
Vasculogenesis by transplanted cells
The cross-sections at 10 lm from frozen tissues, after washing with PBS, were microwaved in target retrieval solution (Dako) diluted with distilled water (1:10 ratio) at 98°C for 10 minutes. Then, after treatment with a streptavidin/biotin blocking kit (Vector Laboratories) to block endogenous biotin, sections were incubated with 5% goat serum/1% BSA/PBS for 30 minutes at RT. For the preparation of primary Ab to human CD31, mouse anti-human CD31 Ab and biotinylated goat anti-mouse IgG (Fitzgerald Industries International Inc., Acton, MA) were, respectively, diluted in 1% BSA/PBS (1:8 and 1:48 ratio), that is, adjusted to the concentration of 25 and 60 lg/mL. The prediluted reagents were mixed in the equal volume and reacted at RT for 1 hour. The prereacted reagent was further mixed with mouse serum (2:1 ratio; Rockland Immunochemicals, Inc., Gilbertsville, PA) and incubated at RT for 1 hour. The primary Ab reagent for human CD31 was incubated with the tissue sections at 4°C overnight. Sections were washed with PBS and subsequently incubated with streptavidin and Alexa Fluor 594 conjugate prediluted in 1% BSA/PBS (1:90 ratio) at RT for 1 hour. Tissue sections were washed with PBS and finally mounted with
Tissue sections were observed by a confocal laser-scanning microscope (LSM510META; Carl Zeiss GmbH, Jena, Germany). Mouse antihuman CD31 Ab and reagents are detailed in Table 9 .
The acquired images at 0.8 lm z interval (11 sliced images by 10 intervals at total 8-lm thickness) were reconstructed three-dimensional (3D) structures using the function of 3D spectrum analysis. Furthermore, to quantify "vasculogenic properties" in their images, the surface of a volume object in the ROI, was visualized, using an Imaris iso-surface function of 4D Image analysis software (Imaris 6.2.0; Carl Zeiss): murine vessels stained with Isolectin B4-FITC (green) and transplanted cell-derived microvessels stained with Alexa 594-conjugated human specific anti-CD31 Ab (red). The values of microvascular density in 2D image and % volume per image cube in 3D were respectively calculated for the green-or red-colored microvessels.
Murine qRT-PCR of ischemic hindlimb
Mice were sacrificed under adequate anesthetization on day 6 after cell Tx. GCMs of ischemic hindlimbs were harvested for total RNA isolation, mice were perfused with 20 mL of PBS by cardiac puncture to remove circulating blood, and GCMs were resected out and incubated into 1 mL of RNA later at 4°C overnight. After homoginization of GCMs with 1 mL of Trizol (Invitrogen), total RNA was isolated and genomic DNA was digested by DNase I treatment (Invitrogen) at 37°C for 15 minutes. DNase I-treated total RNA was purified by phenol extraction and ethanol precipitation. Two micrograms of purified total RNA was used for cDNA synthesis with the High Capacity cDNA Reverse Transcription kit (Applied Biosystems). cDNA mixture was sequentially diluted by 20-to 160-fold with Milii-Q water (Millipore Corporation, Billerica, MA) after first-strand cDNA synthesis. Using ABI Prism 7700 (Applied Biosystems), TaqMan gene expression assays for diluted cDNA were performed with TaqMan Fast Universal PCR Master Mix (Applied Biosystems), according to the manufacturer's protocol. The amplification of cDNA was as follows: denaturation at 95°C for 3 seconds, annealing/ extension at 62°C for 30 seconds, and 40 cycles. The relative mRNA expression was calculated by the ΔΔCt method with normalization to mouse 18S rRNA. All primers and TaqMan probes used are listed in Table 10 .
Statistical Analysis
Prism5 software (GraphPad Software Inc., Cary, NC) was used to conduct all statistical analyses. Wilcoxon's signed-rank test were applied to compare the data between 2 groups and among 3 to 4 groups. The experiment to assess angiovasculogenic properties by transplanted human cells using a confocal fluorescence microscope was performed simultaneously on the whole groups: IMDM control, PBMNCTx, eEPCTx, QQMNCTx, and GmCD34Tx. The data were separately analyzed in the following comparisons: QQMNCTx versus PBMNCTx or IMDM control and QQMNCTx versus GmCD34Tx, eEPCTx, or IMDM control. Especially, vasculogenic properties by transplanted human cells were compared in the groups, excludingd IMDM control. qRT-PCR assay to evaluate mRNA expression in ischemic hindlimbs was also implemented simultaneously on the whole groups; the data were analyzed and compared in the same manner as those in the former experiment. Furthermore, in the assay, the ratio of relative mRNA expression of ischemic-to-contralateral (healthy) hindlimbs in IMDM control was compared by Mann-Whitney's U test to confirm the ischemic response. In histological assays, 2 tissue sections per mouse were prepared, and 4 to 6 fields per tissue section were evaluated. Probability values of P<0.05 were deemed statistically significant. All values are expressed as meanAESE.
Results
Decrease in Cell Counts in QQMNCs
The fold increase of QQMNCs to PBMNCs per well declined in the whole subjects with an average of 0.54-fold (Table 11 ). The calculated total QQMNCs derived from 100 mL of PB Figure 1A ; Table 11 ). Interestingly, the fold increase of QQMNCs per well exhibited the negative correlation with total cells of PBMNCs from 100 mL of PB in healthy subjects ( Figure 1B, left) . Taken together, these findings indicate that even using higher PBMNC densities per 100 mL of PB resulted in constant relative yields of QQMNCs per the PB volume ( Figure 1B, right) .
Increase of Colony-Forming EPCs in QQMNCs
To assess vasculogenic activities between PBMNCs and QQMNCs, EPC-CFA was used to monitor 2 different types of EPC-CFUs, pEPC-CFUs, and dEPC-CFUs, which comprised small cells and large cells, respectively. pEPCs had high cell proliferation activity; in contrast, dEPCs had high vasculogenic potential. 12 Briefly, for in vitro assays, dEPCs had higher cell adhesion activity than did pEPCs, and dEPCs formed tube-like structures; additionally, dEPCs extensively formed blood vessel de novo after Tx into ischemic hindlimbs of mice, but pEPCs did less.
Therefore, pEPCs derive from relatively immature, highly proliferative EPCs, whereas dEPCs are relatively mature, differentiated, and able to promote EPC-mediated cell functions required for vasculogenesis.
The pEPC and dEPC colony-forming cells (CFCs) each constituted a small proportion of the cells in primary PBMNC populations (8910 À4 % and 3.5910 À4 %, respectively; Figure 1C and 1D, left; Table 11 ). These colony assays demonstrated that QQMNCs have much greater vasculogenic potential than do PBMNCs. After QQ culture, the frequency of total EPCCFUs from 2910 5 cells per dish in QQMNCs was significantly enhanced by 13.7-fold of that in PBMNCs. Especially, the frequency of dEPC-CFUs increased by 41.4-fold of that in PBMNCs.
The present data indicate that the vascular regenerative capacity of QQMNCs was superior to that of PBMNCs ( Figure 1D, left) .
Although QQ culture reduced the count of cells in each individual culture, dEPC-CFCs, and total EPC-CFCs in QQMNCs, derived from the even blood volume were enriched 19.0-and 6.2-fold, relative to those in PBMNCs (Figure 1D , middle; Table 11 ). Not only were QQ culture enriched with dEPC-CFCs, but also the EPC-CFCs in QQMNCs had a 2.7-fold greater differentiation potential than those in PBMNCs, considering the percentage of dEPC-CFUs to total EPC-CFUs per dish in PBMNCs and QQMNCs ( Figure 1D, right) .
We also used a linear regression analysis to compare between PBMNCs and QQMNCs with regard to both the quantity and quality of EPC-CFUs ( Figure 1E) .
Notably, dEPC-CFU and total EPC-CFU counts in QQMNCs were positively correlated with pEPC-CFU counts in PBMNCs, but pEPC-CFU counts in QQMNCs were not ( Figure 1E, left) . In contrast, neither pEPC-CFU counts nor total EPC-CFU counts in QQMNCs were positively correlated with dEPC-CFU counts in PBMNCs ( Figure 1E, middle) .
In summary, the frequency of EPC-CFCs in QQMNCs depended on that in PBMNCs ( Figure 1E, right) . Importantly, the frequency of dEPC-CFCs in QQMNCs was positively correlated with that of pEPC-CFCs in PBMNCs; these correlations indicate that the differentiation during QQ culture of pEPC-CFCs in PBMNCs contributed to formation of dEPC-CFCs in QQMNCs.
Collectively, assays of colony formation demonstrated that the quantitative and qualitative vasculogenic potential of QQMNCs is drastically enhanced, relative to that of PBMNCs, when evaluated even by blood volume.
Moreover, we assessed the functional relationship between CD34 + cells and CD34 + cell-depleted MNCs (CD34-MNCs) in
PBMNCs during QQ culture ( Figure 1F 
Cell Population Transition in QQMNCs
Based on microscopy and fluorescent cell sorting, large cells were proportionally more common in QQMNC than in PBMNC samples (Figure 2A and 2B) . In FCM, the proportion of each positive cell involved in the whole cells of (a), (b), and (c) gates separated with red lines was estimated ( Figure 2B) .
QQMNCs exhibited the enrichment of CD34 + and CD133 + stem cell populations, compared to PBMNCs (5.97-fold in CD34 + cells; 3.59 in CD133 + cells; Figure 2C ; was lower in QQMNC than in PBMNC samples. The proportion of endothelial lineage cells was slightly increased in CD105, whereas it was not changed in CD31 and slightly decreased in vWF. Although not significant, the proportion was slightly increased in CD146, while decreased in VEGF receptor (VEGFR)-2.
In the T-lymphoid cell population, and particularly in the angiogenic T-cell subpopulation, C-X-C chemokine receptor Figure 2D ; Table 13 ). These data indicate that QQ culture conditions specifically selected for and/or promote proliferation of stem/progenitor cell populations of EPCs as well as anti-inflammatory and angiogenic monocytes/T-lymphocytes in primary PBMNC cultures. 
Enhanced Gene Expression for Vascular Regeneration and Anti-Inflammation in QQMNCs
Expression of genes encoding vascular regeneration factors, including VEGF-B, angiopoietin-1 (Ang-1), leptin, IL-8, IL-10, and insulin-like growth factor 1 (IGF-1), was much higher in QQMNCs than in PBMNCs; the fold increases in QQMNCs versus PBMNCs were 4.2 for VEGF-B, 2.4 for Ang-1, 35.9 for leptin, 6.3 for IL-8, 5.4 for IL-10, and 21.2 for IGF-1 ( Figure 3A and 3B) . Especially, VEGF-B and Ang-1 also induce vascular maturation, 33, 34 and IGF-1 exerts myogenic potential. 35 Additionally, expression of the gene encoding IL-1b, a proinflammatory cytokine, in QQMNCs decreased by 0.23-fold of that in PBMNCs, with the increase of the gene encoding the anti-inflammatory IL-10 ( Figure 3C ). These expressional profiles indicate that QQMNCs preferred to arrange an antiinflammatory environment in injured tissue. Furthermore, the expression of genes encoding to matrix metalloproteinases (MMPs) of MMP-2 and -9 was significantly higher in QQMNCs than in PBMNCs; the fold increases were 22.1 for MMP-2 and 189.4 for MMP-9 ( Figure 3D ). MMP-2 and -9 have antifibrotic activity that plays critical roles during neovascularization and tissue remodeling.
36,37
QQMNCs Promote Angiogenesis In Vitro
Using an in vitro Matrigel assay, we found that QQMNCs promoted tube formation of cocultured HUVECs for 12 hours, but PBMNCs did not (tube counts/92 HPF=63.3AE1.43 for HUVEC+QQMNC versus 55.1AE1.45 for HUVEC+PBMNC or 55.3AE1.39 for HUVEC alone; Figure 4A and 4B).
Moreover, QQMNCs were readily incorporated into the tubes formed by HUVECs; in contrast, PBMNCs were rarely incorporated into such tubes (incorporated DiI-uptaking cells in tubes/94 HPF=38.5AE8.30 for QQMNC versus 8.72AE1.89 for PBMNC; Figure 4C and 4D).
These findings indicate that in vitro QQMNCs had more angiogenic-and EPC-incorporating activity than did PBMNCs. 
Physiological Recovery of Blood Perfusion in Ischemic Hindlimb After QQMNCTx
We investigated the potential of QQMNCs to treat ischemia, using a mouse ischemic hindlimb model; the effect was evaluated by blood flow measurement for 21 days after ischemic surgery. We compared the effect of QQMNCTx with that of no-cell Tx (IMDM medium-injected mice:IMDM control) or PBMNCTx ( Figure 5A ). For each mouse, we measured blood flow in the ischemic and contralateral hindlimb; we then calculated the ratio of ischemic blood flow to contralateral flow: % blood flow ratio in the QQMNCTx, PBMNCTx, and control groups=at day 14 The % ratios of autoamputation in the QQMNCTx, PBMNCTx, and control groups were 4.3, 9.5, and 15.8, respectively; conversely, those of limb salvage were 21.7, 9.5, and 10.5, respectively. These findings indicate that QQMNCTx potentiated physiological recovery in hindlimb ischemia more so than did PBMNCTx or control ( Figure 5C ).
When compared to GmCD34Tx and eEPCTx, the % ratios of autoamputation in QQMNCTx, GmCD34Tx, and eEPCTx were 4.5, 26.3, and 37.5, respectively. In contrast, those of limb salvage in QQMNCTx, GmCD34Tx, and eEPCTx were 27.3, 21.1, and 25.0, respectively.
Regarding these findings, the earlier blood flow recovery by QQMNCTx might favorably rescue the ischemic foot from injury, compared to other treatments ( Figure 5D ).
QQMNCTx Potentiates Vascular and Muscle Regeneration in Ischemic Hindlimb
Angiogenesis and arteriogenesis
For each animal, we used histological methods to measure Isolectin B4-FITC stained microvessel density and assess angiogenic capacity in the ATM of ischemic hindlimbs; the mean densities (microvessel counts/mm 2 ) for the QQMNCTx, PBMNCTx, and control groups were 400.7AE37.9, 118.9AE20.1, and 98.7AE15.8, respectively ( Figure 6A and 6B). We also evaluated pericyte-recruited (a-SMA + ) microvessel densitiy in the ATM to assess arteriogenesis for vascular maturation: The mean densities (pericyte-recruited microvessel counts/mm 2 ) for the QQMNCTx, PBMNCTx, and control groups were 38.7AE5.5, 19.8AE4.3, and 15.0AE2.7, respectively ( Figure 6A and 6C) . Likewise, the mean microvessel densities (microvessel counts/ mm 2 ) for the QQMNCTx, GmCD34Tx, eEPCTx, and control groups were 510.7AE30.0, 430.6AE29.8, 347.9AE36.5, and 210.5AE16.8 respectively (Figure 6D and 6E) . The mean pericyte-recruited microvessel densities (pericyte-recruited microvessel counts/mm 2 ) for the QQMNCTx, GmCD34Tx, eEPCTx, and control groups were 42.6AE4.3, 39.5AE3.8, 29.8AE2.0, and 23.2AE2.9, respectively ( Figure 6D and 6F ). These findings demonstrate that QQMNCTx promoted angiogenesis and arteriogenesis for vascular maturation.
Vasculogenesis
We performed in vivo experimenents to assess vasculogenic properties of transplanted cells (2910 5 cells/mouse): to investigate whether and to what extent transplanted cells differentiate into endothelial cell forming vascular structure in the host tissue, using a confocal fluorescence microscope ( Figure 7A ; Video S1). IHC stainings demonstrated the significantly higher vasculogenic microvessel counts in QQMNCTx muscles than those in PBMNCTx (Figure 7B through 7D ; Table 14 ).
The average vasculogenic microvessel densities in 2D image (vasculogenic microvessel counts/mm 2 ) for the QQMNCTx and PBMNCTx groups were 811.6AE178.6 and 202.9AE97.3 ( Figure 7C) ; the % ratios of vasculogenic microvessel volume per image cube for the respective groups were 0.76AE0.17 and 0.05AE0.04 ( Figure 7D ). The potential of QQMNCTx was also markedly superior to that of eEPCTx, whereas it was equal to or greater than that of Table 14) . Similarly, the angiogenic properties of transplanted cells, here evaluated by the confocal microscopic analysis, exhibited the compatible feature with those in the aforementioned 
Myogenesis
Muscle fibers with centrally located nuclei indicate myogenesis mediated by fusion of myoblasts in ATM of ischemic hindlimbs; therefore, we determined that the average densities of such regenerating muscle fibers (regenerating muscle fibers/mm 2 ) for the QQMNCTx, PBMNCTx, and control groups were 775.6AE113.3, 424.2AE47.12, and 398.6AE48.42, respectively ( Figure 8A and 8B ).
In the respective experiments to compare myogenesis among the QQMNCTx, GmCD34Tx, eEPCTx, and control groups, we also determined that the average densities of regenerating muscle fibers (regenerating muscle fiber counts/ Figure 8C and 8D ). These findings indicate that QQMNCTx potentiated myogenesis greater than PBMNCTx and control, or equal to GmCD34Tx in ischemic hindlimbs, although did not compare to eEPCTx.
Inhibitory Effects of QQMNCTx to Fibrosis and Inflammation in Hindlimb Ischemia
To evaluate anti-inflammatory and -fibrotic potential of QQMNCTx, fibrotic area in ischemic ATM was detected by Azan staining on day 21 after treatment. The mean fibrotic area (% fibrotic area/940 HPF) for the QQMNCTx, PBMNCTx, and control groups were 2.78AE0.61, 8.41AE1.51, and 11.94AE3.59.
These findings indicate that QQMNCTx exerted greater antifibrotic effects than did PBMNCTx ( Figure 9A and 9B ).
In the respective comparison among the QQMNCTx, GmCD34Tx, eEPCTx, and control groups, the mean fibrotic areas (% fibrotic area/940 HPF) for each group were 5.89AE1.12, 8.06AE1.05, 11.07AE1.19, and 17.04AE1.75 (Figure 9C and 9D ). QQMNCTx as well as GmCD34Tx featured superior antifibrotic effects to control and further exerted greater effects than eEPCTx.
We performed IHC of iNOS in ischemic ATM to assess inflammation. The mean iNOS-expressing areas (% iNOSexpressing area/920 HPF) for the QQMNCTx, PBMNCTx, and control groups were 3.16AE0.58, 6.26AE0.89, and 21.31AE2.26 ( Figure 10A and 10B) . These findings indicate that QQMNCTx inhibited inflammation more markedly than PBMNCTx. . Each column in the graph represents a meanAESE. 920 HPF. N=6 mice per group. ATM indicates anterior tibial muscle; eEPCTx, early endothelial progenitor cell transplantation; GmCD34, granulocyte colony-stimulating factor mobilized CD34 + cell; H&E, hematoxylin and eosin; HPF, high power field; PBMNCTx, peripheral blood mononuclear cell transplantation; QQMNCTx, quality and quantity control culture of mononuclear cell transplantation.
In the respective comparison among the QQMNCTx, GmCD34Tx, eEPCTx, and control groups, the mean iNOSexpressing areas (% iNOS-expressing area/920 HPF) for the respective groups were 4.97AE0.95, 6.07AE0.81, 9.75AE1.09, and 18.15AE1.44 ( Figure 10C and 10D) . In the same manner as antifibrotic aspects, QQMNCTx as well as GmCD34Tx featured superior anti-inflammation effects to control and further displayed greater effects than eEPCTx.
These findings indicate that QQMNCTx, similarly to GmCD34Tx, potentiated protective effects against inflammation and fibrosis in the ischemic hindlimb.
QQMNCTx Enhances Gene Expression for Tissue Regeneration in Ischemic Muscle
The qRT-PCR assay was implemented for murine mRNA transcripts encoding the following factors: IL-1b (proangiogenic/-inflammatory), transforming growth factor beta (TGF-b; proangiogenic/anti-inflammatory), IGF-1 (proangiogenic/-myogenic), or MyoD1 and myogenin (promyogenic transcription).
In the comparison of the murine transcripts among the QQMNCTx, PBMNCTx, and control groups, gene expression of MyoD1, myogenin, and IGF-1 was significantly augmented by responding to QQMNCTx, but not to PBMNCTx.
Likewise, in the comparison among the QQMNCTx, GmCD34Tx, and eEPCTx groups, gene expression of MyoD1, myogenin, and IGF-1 was significantly enhanced by responding to QQMNCTx, equally to GmCD34Tx, but not to eEPCTx.
The relative ratio of each gene expression in PBMNCTx, QQMNCTx, GmCD34Tx, and eEPCTx versus that in IMDM control was as follows: Figure 11A and 11B) .
The gene expression of TGF-b was fairly promoted by responding to QQMNCTx, rather than to PBMNCTx, and also enhanced equal to or higher than that in GmCD34Tx, although not in eEPCTx. The relative ratio of TGF-b gene expression in PBMNCTx, QQMNCTx, GmCD34Tx, and eEPCTx, control, was 3.14AE0.42, 4.35AE0.60, 3.52AE0.36, and 0.52AE0.04 (Figure 11A and 11B) .
Thus, gene expressions of the potent factors for angiogenesis, myogenesis, and anti-inflammation reacting to QQMNCTx as well as GmCD34Tx were similarly up-regulated, when compared with those to PBMNCTx or eEPCTx.
Above all, the gene expression encoding IGF-1 to QQMNCTx was unambiguously enhanced, compared with that to the other Tx groups of PBMNCTx and eEPCTx. The findings correspond with the histological results to show the multifunctional mechanisms of QQMNCTx as superior to those of PBMNCTx or eEPCTx.
Notably, Tx of all cell sources, more or less, up-regulated gene expression of IL-1b, a proinflammatory factor, whereas unpurified EPC Tx of QQMNCs as well as PBMNCs tended to produce the transcript more drastically than the purified EPC Tx of GmCD34 or eEPCs. The relative ratio of IL-1b gene expression in QQMNCTx, GmCD34Tx, and eEPCTx versus that in IMDM control was 32.00AE12.74, 10.47AE2.27, and 19.53AE7.78, respectively.
In the present experiments, PBMNCTx, despite the fairly high expression of IL-1b, did not exert angiogenic ability, whereas GmCD34Tx, even in the lesser expression, did so favorably. In other words, IL-1b production in ischemic tissue responding to any cell Tx did not seemingly contribute to angiogenesis for vascular regeneration.
Discussion
Here, we developed and characterized QQMNCs (novel therapeutic cells), QQMNCs derived from PBMNCs that were subjected to QQ culture, and this QQ culture promoted expansion of EPCs and adoption of regenerative phenotypes by macrophages and T lymphocytes. The QQ culture that we used to generate QQMNCs was based on a well-established QQ culture that increases the quality and quantity of EPCs from enriched EPC populations, such as CD34 + and CD133 + cells; this established QQ culture was used to generate therapeutic stem cells for CV regeneration in rat infarcted myocardia. 23 We found here that the vasculogenic signaling condition of this QQ culture potentiated the vascular regeneration ability of na€ ıve PBMNCs to produce QQMNCs. QQMNCs were superior to PBMNCs, and equal to or greater than GmCD34 cells, in terms of regeneration abilities, including vascular regeneration (angiogenesis, arteriogenesis, and vasculogenesis), myogenesis, anti-inflammation, and antifibrosis.
EPC Expansion and Differentiation in QQMNCs
EPC-CFA of QQMNCs demonstrated intensive expansion potential of colony-forming EPCs, especially dEPCs (Figure 1D) . The concept of colony-forming EPCs was recently introduced.
12,38 pEPCs in small-sized EPC colonies showed a higher rate of proliferation and a higher percentage of cells in S-phase, when compared to dEPCs in large-sized EPC colonies. In contrast, dEPCs had a significantly higher capacity for vasculogenic activity than did pEPCs; similarly, dEPCs also had a greater overall potential for cell adhesion and formation of tube-like structures in vitro; importantly, dEPCs had a greater capacity than pEPCs to support de novo blood vessel formation in vivo after transplantation into ischemic models. Therefore, pEPCs are defined as very immature, highly proliferative EPCs; in contrast, dEPCs are believed to derive from pEPCs and represent cells prone to differentiation and promotion of vasculogenesis. These dEPCs are proven to play a key role in vasculogenesis, and to be suitable for vascular regeneration therapy. In this regard, QQ culture promoted significant expansion and commitment of colony-forming EPCs with vasculogenic potential.
To confirm colony-forming EPC expansion in QQ culture of na€ ıve PBMNCs, we evaluated EPC colony-forming activity before and after QQ culture ( Figure 1E ). Total EPC-CFU count in QQMNC samples was correlated with that in PBMNC samples. For example, pEPC-CFU count in PBMNC samples correlated with dEPC-CFU count and with total EPC-CFU count in QQMNC samples, but not with pEPC-CFU count in QQMNC samples. The dEPC-CFU count in PBMNC samples did not correlate to any EPC-CFU count in QQMNC samples. These data indicate that signals in QQ culture probably induced concurrent expansion and differentiation of pEPC-CFCs, resulting in an increase in the dEPC-CFC population instead of the pEPC-CFC population. Consequently, the enhanced vasculogenic potential of post QQ culture-treated cells, compared with the precursor PBMNCs, explained the preferential vascular regeneration.
Cell Populations in QQ Cultures
The cell numbers of QQMNCs were, on average, approximately half of those in the respective PBMNCs. The cellular density of PBMNCs per blood volume is inversely correlated with the ratio of cellular density per well between PBMNCs and QQMNCs. Therefore, the QQMNC numbers are rather dependent on the original blood volume per se ( Figure 1B) .
From the view of cell populations, the decrease in total cell count is mainly derived from significant reduction of B lymphocytes (CD19 + Therefore, the cell-cell interactions among M2 macrophages, Th2, and regulatory T cells are considered to accelerate QQMNCs function as angiogenic and anti-inflammatory tools.
Of note, the majority of T lymphocytes in QQ cultures are CXCR4 + /CD31 + /CD3 + cells. This population is called "angiogenic T cells" in the vascular biology field; these T cells deliver proangiogenic cytokines in tissues for neovascularization.
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The finding also encourages that the phenotype of T lymphocytes is conducible to angiogenic preference of QQMNCs. Therefore, QQMNCs signal regenerative switches on PBMNCs not only by EPC expansion and differentiation, but also through collaborative M2 macrophage polarization and Th2 and regulatory T-cell activation in QQ culture.
Cross-Talk of Cell Populations in QQMNCs
The finding shown in Figure 1F indicates that CD34 + celldepleted PBMNCs included some cell population to accelerate EPC expansion and differentiation in CD34 + cells through QQ culture. As demonstrated in Figure 2C and 2D, EPCs, M2 macrophage, Th2, and regulatory T lymphocytes were mainly activated in QQMNCs. Increasingly, researches are focused on the interaction between macrophages and T lymphocytes to elucidate the collaborative mechanism of inflammation and immunity. Although we do not have any evidence to indicate that EPCs are involved in this collaboration, the developed culture for EPC expansion, QQ culture, regulates phenotypes of macrophages and T lymphocytes and, consequently, exerts EPC expansion and differentiation. Therefore, any cellular or molecular mechanism responsible for the effects of CD34 + cell-depleted PBMNCs needs to be identified in the future for scientific and therapeutic interests.
Factors Expressed From QQMNCs
In order to further examine the vasculogenic potential of QQMNCs, qRT-PCR was used to determine gene expression profiles. In QQMNCs, the expression of mRNAs encoding antiinflammatory and proangiogenic factors was enhanced, whereas that of mRNAs encoding proinflammatory cytokines declined ( Figure 3) . Expression of mRNAs encoding proangiogenic cytokines and growth factors (eg, IL-10, 43 35 ; this phenomenon may be reflected in the findings of enhanced myogenesis after QQMNCTx. VEGF-B and Angn-1 were up-regulated in QQMNCs, and they potentiate vascular survival and maturation relating to arteriogenesis induced by pericyte recruitment. 33, 34 However, expression of mRNA encoding VEGF-A, one of the main proangiogenic growth factors, was not elevated, but rather reduced in QQMNCs, relative to PBMNCs. The reduction of VEGF-A expression might be explained by a negative feedback mechanism through high dose of VEGF-A protein in QQ culture conditioning. In contrast, expression of mRNA encoding TGF-b, one of the potent anti-inflammatory factors, was lower in QQMNCs. However, expression of mRNAs encoding TNF-a and IL-1b, the important proinflammatory mediators, was similarly mitigated between QQMNCs and PBMNCs for TNF-a while prominently down-regulated in QQMNCs and in PBMNCs for IL-1b.
The findings indicate that QQMNCs may not, at least, bring proinflammatory cell populations more than PBMNCs.
Moreover, the expression of mRNAs encoding MMP-2 or -9, which, playing a critical role in neovascularization and tissue remodeling for antifibrosis, 36 were highly up-regulated.
Taken together, QQMNCTx, compared to PBMNCTx, resulted in more favorable conditions for vascular regeneration or tissue repair because of the orchestration of dynamic expression of multiple cytokines and growth factors.
Therapeutic Potential of QQMNCs for Hindlimb Ischemia Models
QQMNCs have therapeutic potential because transplantation of the cells into ischemic hindlimb tissue was associated with increased blood flow, limb survival, and neovascularization in tissues ( Figure 5 ). Moreover, histological findings indicate that transplanted human QQMNCs contributed to new microvessel formation composed of human cells derived from EPCs in QQMNCs, as well as mouse microvessel formation and arteriogenesis supported by pericytes (Figures 6 and 7) . The latter effects were presumably the result of angiogenic paracrine effects by accelerated phenotypes of macrophages and T lymphocytes as well as EPCs.
The other categorical finding of this transplantation treatment was decreased fibrosis and inflammation as well as enhanced myogenesis (Figures 8 through 10) . As indicated by cell population study and gene expression analyses, QQMNCs included many anti-inflammatory M2 macrophages; the cells had enhanced expression of the anti-inflammatory cytokine, IL-10, and the anti-fibrotic proteases, MMP-2 and -9, as well as decreased expression of the proinflammatory cytokine, IL-1b. This anti-inflammatory effect by QQMNCs conceivably protected against fibrosis, even in severe ischemic muscles. Moreover, skeletal myogenesis was also augmented by transplantation of QQMNCs with enhanced expression of mRNA encoding IGF-1.
Thus, we demonstrated that transplanted QQMNCs per se provide the favorable microenvironment for injured tissue regeneration by exerting vascularization as well as antiinflammatory and myogenic effects.
As recently reported, 7 in a human subject of 50 kg body weight. We implanted far fewer cells than are generally used for clinical treatments. Therefore, the effect of PBMNCs on ischemic hindlimbs was minimal, whereas QQMNCTx had extensive therapeutic effects on vascular regeneration and tissue repair. On the other hand, the cell dose of 1910 4 cells per mouse subject also corresponds to that used at transplantation of G-CSF-mobilized CD34 + cells in patients with critical limb ischemia. 17, 19 Of note, in the present study, QQMNCTx exerted the experimental efficacy equal to or in part greater than that of GmCD34Tx. The count of transplanted QQMNCs (1910 4 cells/ mouse) for therapeutic activity of tissue regeneration corresponds to cell quantity, on average, acquired from <100 mL of PB of human subjects. The isolation and preparation of QQMNCs require only the MNC isolation and a week culture in QQ culture conditions that included recombinant factors without any manipulation. Furthermore, the process avoids invasive procedures for isolation, such as BM cell isolation or leukapheresis, and expensive costs for mobilization and target cell isolation, such as G-CSF administration or CD34 + /CD133 + cell isolation using magnetic beads. Collectively, the QQMNC is expected to be an advantageous and feasible cell source for cell-based therapy targeting ischemic diseases.
Responsive Mechanism in Ischemic Hindlimb for Tissue Regeneration After QQMNCTx
Histochemistry (Figures 8 through 10 ) and qRT-PCR assay ( Figure 11 ) demonstrated that QQMNCTx, as well as GmCD34Tx, provides the preferential environment for tissue regeneration of myogenesis, antifibrosis, and anti-inflammation in the ischemic hindlimb.
With respect to qRT-PCR assay, IL-1b, a proinflammatory cytokine, has been reported to function as a proangiogenic factor derived from regenerating myoblasts responding to PBMNC implantation in the ischemic hindlimb. 51 In the present study, implantation of PBMNCs highly induced the expression of mRNA encoding IL-1b in ischemic tissue, similarly to that of QQMNCs, whereas it did not demonstrate great angiogenic potential. The causes of the dissimilar response might be presumably attributed to the distinct animal experiments using different murine strains with various cell doses for transplantation: immunodeficient BALB/c nu/ nu nude mice (1910 4 cells/mouse) in our study and C57BL/ 6 mice (1910 6 cells/mouse) elsewhere. 51 Notably, QQMNCTx, similarly to GmCD34Tx, up-regulated the gene expression of mRNAs encoding promyogenic factors of IGF-1, 52 MyoD1, and myogenin in the ischemic hindlimb; Tx of those cell types induced preferential myogenesis, unlike Tx of the other cell candidates, in histological evaluation. This means that the effective myogenesis by cell transplantation may primarily require in situ IGF-1 production, which also signifies a myogenic biomarker in the ischemic hindlimb. Regarding the results, skeletal muscle-restricted expression of IGF-1 in transgenic mice has been reported to not only accelerate muscle regeneration, but also to exert the protective effects against inflammation and fibrosis in the injured skeletal muscle. 53 Moreover, IGF-1 has been reported to inhibit nuclear factor kappa B activation through TNF-a 54 or proapoptotic miRNA expression 55 in ischemic cardiomyocytes. Therefore, IGF-1 supplied to ischemic tissue by local QQMNCTx is adequately conceived to exert the protective effect on inflammation, fibrosis, or tissue injury. Also, QQMNCs per se exhibited enhanced expression of mRNA encoding human IGF-1 ( Figure 3A) . Likewise, QQMNCTx, as well as GmCD34Tx, up-regulated expression of mRNA encoding TGF-b, a potent inhibitory factor of inflammation, in transplanted tissue, although QQMNC in vitro exhibited lesser expression than PBMNCs. Unlike the aspect of IGF-1, the responsive tissue expression in situ of TGF-b after cell transplantations, might contribute to protecting against inflammation, rather than the expression by the transplanted cells.
Take together, expression of IGF-1 or TGF-b by injured tissue responsive to QQMNCTx, as well as that of IGF-1 and other tissue regeneration mediators by the transplanted cells per se, are expected to reveal the mechanism underlying the preferential efficacy of cell Tx.
Limitation of the Present Study
In the present study, recipients' T-lymphocyte-deficient condition in athymic BALB/c nu/nu nude mice limits the insight into regeneration mechanism by regulatory effects on host immune response through regulatory T cells increased in QQMNCs. Therefore, the relevant animal model studies are required to elucidate the essential effect of QQMNCTx in future experiments.
Conclusion
The QQ culture system for whole PBMNCs that we described here may lead to an effective cell-based therapy to alleviate the physical burdens in patients as one feasible strategy for vascular regeneration or tissue repair.
